Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Addex raises CHF3.2 million

Addex Therapeutics Ltd. (SIX:ADXN) raised CHF3.2 million ($3.5 million) through the sale of 1.2 million

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE